Ensysce Biosciences, Inc. rose 10.0% on Monday, November 9, 2026, on 226,100 shares. No headline about ENSC came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Ensysce Biosciences, Inc. (ENSC:NASDAQ) closed at $0.418 on November 13, 2026, up 8.06% on the day. The stock trades 80.7% below its 52-week high of $2.17 and 81.9% above its 52-week low of $0.230. Over the past year, it lost 78.7%. Ensysce Biosciences, Inc. is part of the Finance sector.
In 252 trading sessions since November 13, 2025, ENSC closed higher on 104 days (41%). Its best day was February 27, 2026 (+57.72%) and its worst was February 10, 2026 (-27.47%). The stock moved 10% or more in a single session 35 times. It opened at least 5% above the previous day's high 4 times.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost.
Find more stocks like ENSC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.